Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

576

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

liraglutide

DRUG

rosiglitazone

DRUG

metformin

Trial Locations (89)

11203

Novo Nordisk Investigational Site, Brooklyn

11768

Novo Nordisk Investigational Site, Northport

12206

Novo Nordisk Investigational Site, Albany

14621

Novo Nordisk Investigational Site, Rochester

20010

Novo Nordisk Investigational Site, Washington D.C.

20782

Novo Nordisk Investigational Site, Hyattsville

23294

Novo Nordisk Investigational Site, Richmond

23606

Novo Nordisk Investigational Site, Newport News

27710

Novo Nordisk Investigational Site, Durham

27834

Novo Nordisk Investigational Site, Greenville

28803

Novo Nordisk Investigational Site, Asheville

29334

Novo Nordisk Investigational Site, Duncan

30032

Novo Nordisk Investigational Site, Atlanta

30034

Novo Nordisk Investigational Site, Atlanta

30127

Novo Nordisk Investigational Site, Powder Springs

30318

Novo Nordisk Investigational Site, Atlanta

30606

Novo Nordisk Investigational Site, Athens

32204

Novo Nordisk Investigational Site, Jacksonville

32746

Novo Nordisk Investigational Site, Lake Mary

33324

Novo Nordisk Investigational Site, Plantation

33907

Novo Nordisk Investigational Site, Fort Myers

37404

Novo Nordisk Investigational Site, Chattanooga

38801

Novo Nordisk Investigational Site, Tupelo

40503

Novo Nordisk Investigational Site, Lexington

43203

Novo Nordisk Investigational Site, Columbus

43212

Novo Nordisk Investigational Site, Columbus

44060

Novo Nordisk Investigational Site, Mentor

44195

Novo Nordisk Investigational Site, Cleveland

45245

Novo Nordisk Investigational Site, Cincinnati

45406

Novo Nordisk Investigational Site, Dayton

45429

Novo Nordisk Investigational Site, Kettering

47150

Novo Nordisk Investigational Site, New Albany

50314

Novo Nordisk Investigational Site, Des Moines

53209

Novo Nordisk Investigational Site, Milwaukee

61615

Novo Nordisk Investigational Site, Peoria

63110

Novo Nordisk Investigational Site, St Louis

66606

Novo Nordisk Investigational Site, Topeka

70121

Novo Nordisk Investigational Site, New Orleans

70808

Novo Nordisk Investigational Site, Baton Rouge

75230

Novo Nordisk Investigational Site, Dallas

75231

Novo Nordisk Investigational Site, Dallas

75246

Novo Nordisk Investigational Site, Dallas

76014

Novo Nordisk Investigational Site, Arlington

77025

Novo Nordisk Investigational Site, Houston

77030

Novo Nordisk Investigational Site, Houston

78209

Novo Nordisk Investigational Site, San Antonio

78229

Novo Nordisk Investigational Site, San Antonio

79707

Novo Nordisk Investigational Site, Midland

84102

Novo Nordisk Investigational Site, Salt Lake City

85395

Novo Nordisk Investigational Site, Goodyear

89502

Novo Nordisk Investigational Site, Reno

90024

Novo Nordisk Investigational Site, Los Angeles

90057

Novo Nordisk Investigational Site, Los Angeles

90822

Novo Nordisk Investigational Site, Long Beach

91978

Novo Nordisk Investigational Site, Spring Valley

92025

Novo Nordisk Investigational Site, Escondido

92037

Novo Nordisk Investigational Site, La Jolla

92324

Novo Nordisk Investigational Site, Colton

92691

Novo Nordisk Investigational Site, Mission Viejo

92705

Novo Nordisk Investigational Site, Santa Ana

92869

Novo Nordisk Investigational Site, Orange

93105

Novo Nordisk Investigational Site, Santa Barbara

94520

Novo Nordisk Investigational Site, Concord

99218

Novo Nordisk Investigational Site, Spokane

06050

Novo Nordisk Investigational Site, New Britain

83404-7596

Novo Nordisk Investigational Site, Idaho Falls

08009

Novo Nordisk Investigational Site, Berlin

08536

Novo Nordisk Investigational Site, Plainsboro

27599-7172

Novo Nordisk Investigational Site, Chapel Hill

75390-8858

Novo Nordisk Investigational Site, Dallas

79430-8183

Novo Nordisk Investigational Site, Lubbock

T2H 2G4

Novo Nordisk Investigational Site, Calgary

T5J 3N4

Novo Nordisk Investigational Site, Edmonton

R3E 3P4

Novo Nordisk Investigational Site, Winnipeg

B3H 1V7

Novo Nordisk Investigational Site, Halifax

N6A 4V2

Novo Nordisk Investigational Site, London

K1N 6N5

Novo Nordisk Investigational Site, Ottawa

M5C 2T2

Novo Nordisk Investigational Site, Toronto

H7T 2P5

Novo Nordisk Investigational Site, Laval

J8T 8M1

Novo Nordisk Investigational Site, Gatineau

L5M 2V8

Novo Nordisk Investigational Site, Mississauga

H2W 1R7

Novo Nordisk Investigational Site, Montreal

H3A 1A1

Novo Nordisk Investigational Site, Montreal

G1V 4G2

Novo Nordisk Investigational Site, Québec

T4N 6V7

Novo Nordisk Investigational Site, Red Deer

A1B 3V6

Novo Nordisk Investigational Site, St. John's

M5G 1X5

Novo Nordisk Investigational Site, Toronto

V5Z 1C6

Novo Nordisk Investigational Site, Vancouver

N8W 3K2

Novo Nordisk Investigational Site, Windsor

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT00333151 - Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes | Biotech Hunter | Biotech Hunter